ERBB2 and neoplasm: By microarray profiling, they screened 12 patients (matched on age at diagnosis, tumor size, grade, nodal status, PgR-and Her2/neu-status, ER immune reactive (IR) score and radiotherapy) with (n = 6) and without (n = 6) relapse following five years of tamoxifen treatment for 1105 microRNAs.